Literature DB >> 27143262

Increasing the immune activity of exosomes: the effect of miRNA-depleted exosome proteins on activating dendritic cell/cytokine-induced killer cells against pancreatic cancer.

Ri-Sheng Que1, Cheng Lin2, Guo-Ping Ding2, Zheng-Rong Wu2, Li-Ping Cao2.   

Abstract

BACKGROUND: Tumor-derived exosomes were considered to be potential candidates for tumor vaccines because they are abundant in immune-regulating proteins, whereas tumor exosomal miRNAs may induce immune tolerance, thereby having an opposite immune function.
OBJECTIVE: This study was designed to separate exosomal protein and depleted exosomal microRNAs (miRNAs), increasing the immune activity of exosomes for activating dendritic cell/cytokine-induced killer cells (DC/CIKs) against pancreatic cancer (PC).
METHODS: PC-derived exosomes (PEs) were extracted from cultured PANC-1 cell supernatants and then ruptured; this was followed by ultrafiltered exosome lysates (UELs). DCs were stimulated with lipopolysaccharide (LPS), PE, and UEL, followed by co-culture with CIKs. The anti-tumor effects of DC/CIKs against PC were evaluated by proliferation and killing rates, tumor necrosis factor-α (TNF-α) and perforin secretion. Exosomal miRNAs were depleted after lysis and ultrafiltration, while 128 proteins were retained, including several immune-activating proteins.
RESULTS: UEL-stimulated DC/CIKs showed a higher killing rate than LPS- and PE-stimulated DC/CIKs.
CONCLUSIONS: miRNA-depleted exosome proteins may be promising agonists for specifically activating DC/CIKs against PC.

Entities:  

Keywords:  Dendritic cell; Exosome; MicroRNAs; Pancreatic cancer

Mesh:

Substances:

Year:  2016        PMID: 27143262      PMCID: PMC4868825          DOI: 10.1631/jzus.B1500305

Source DB:  PubMed          Journal:  J Zhejiang Univ Sci B        ISSN: 1673-1581            Impact factor:   3.066


  23 in total

1.  Purification, characterization and biological significance of tumor-derived exosomes.

Authors:  Kenichiro Koga; Kotaro Matsumoto; Takashi Akiyoshi; Makoto Kubo; Naoki Yamanaka; Akira Tasaki; Hiroshi Nakashima; Masafumi Nakamura; Syoji Kuroki; Masao Tanaka; Mitsuo Katano
Journal:  Anticancer Res       Date:  2005 Nov-Dec       Impact factor: 2.480

Review 2.  Pancreatic cancer.

Authors:  Audrey Vincent; Joseph Herman; Rich Schulick; Ralph H Hruban; Michael Goggins
Journal:  Lancet       Date:  2011-05-26       Impact factor: 79.321

Review 3.  Improvement of surgical results for pancreatic cancer.

Authors:  Werner Hartwig; Jens Werner; Dirk Jäger; Jürgen Debus; Markus W Büchler
Journal:  Lancet Oncol       Date:  2013-10       Impact factor: 41.316

Review 4.  Attractin: a cub-family protease involved in T cell-monocyte/macrophage interactions.

Authors:  J S Duke-Cohan; W Tang; S F Schlossman
Journal:  Adv Exp Med Biol       Date:  2000       Impact factor: 2.622

5.  miR-132 and miR-212 are increased in pancreatic cancer and target the retinoblastoma tumor suppressor.

Authors:  Jong-Kook Park; Jon C Henry; Jinmai Jiang; Christine Esau; Yuriy Gusev; Megan R Lerner; Russell G Postier; Daniel J Brackett; Thomas D Schmittgen
Journal:  Biochem Biophys Res Commun       Date:  2011-02-15       Impact factor: 3.575

6.  Tumour-derived microvesicles modulate biological activity of human monocytes.

Authors:  Monika Baj-Krzyworzeka; Rafał Szatanek; Kazimierz Weglarczyk; Jarosław Baran; Marek Zembala
Journal:  Immunol Lett       Date:  2007-08-22       Impact factor: 3.685

Review 7.  Multifunctional roles of gelsolin in health and diseases.

Authors:  Guo Hua Li; Pamela D Arora; Yu Chen; Christopher A McCulloch; Peter Liu
Journal:  Med Res Rev       Date:  2010-11-09       Impact factor: 12.944

8.  Distribution and lateral mobility of DC-SIGN on immature dendritic cells--implications for pathogen uptake.

Authors:  Aaron K Neumann; Nancy L Thompson; Ken Jacobson
Journal:  J Cell Sci       Date:  2008-02-12       Impact factor: 5.285

9.  Autologous dendritic cell based adoptive immunotherapy of patients with colorectal cancer-A phase I-II study.

Authors:  János Hunyadi; Csilla András; Imre Szabó; János Szántó; Kornélia Szluha; Sándor Sipka; Péter Kovács; Attila Kiss; Gyula Szegedi; István Altorjay; Péter Sápy; Péter Antal-Szalmás; László Tóth; György Fazekas; Éva Rajnavölgyi
Journal:  Pathol Oncol Res       Date:  2013-10-28       Impact factor: 3.201

Review 10.  The application of exosomes as a nanoscale cancer vaccine.

Authors:  Aaron Tan; Hugo De La Peña; Alexander M Seifalian
Journal:  Int J Nanomedicine       Date:  2010-11-10
View more
  25 in total

1.  Is the exosome a potential target for cancer immunotherapy?

Authors:  Akihiko Yoshimura; Kenjiro Sawada; Tadashi Kimura
Journal:  Ann Transl Med       Date:  2017-03

Review 2.  The role of pancreatic cancer-derived exosomes in cancer progress and their potential application as biomarkers.

Authors:  H Jin; Y Wu; X Tan
Journal:  Clin Transl Oncol       Date:  2017-02-06       Impact factor: 3.405

Review 3.  Role of exosomal non-coding RNAs from tumor cells and tumor-associated macrophages in the tumor microenvironment.

Authors:  Zijie Xu; Yi Chen; Ling Ma; Yizhang Chen; Jingya Liu; Yuchen Guo; Ting Yu; Lianghui Zhang; Lingjun Zhu; Yongqian Shu
Journal:  Mol Ther       Date:  2022-04-09       Impact factor: 12.910

Review 4.  Cancer-derived exosomic microRNAs shape the immune system within the tumor microenvironment: State of the art.

Authors:  Francesca Fanini; Muller Fabbri
Journal:  Semin Cell Dev Biol       Date:  2016-12-09       Impact factor: 7.727

Review 5.  Extracellular vesicles as mediators of the progression and chemoresistance of pancreatic cancer and their potential clinical applications.

Authors:  Jiangdong Qiu; Gang Yang; Mengyu Feng; Suli Zheng; Zhe Cao; Lei You; Lianfang Zheng; Taiping Zhang; Yupei Zhao
Journal:  Mol Cancer       Date:  2018-01-05       Impact factor: 27.401

6.  Expression levels of circulating miRNAs as biomarkers during multimodal treatment of rectal cancer - TiMiSNAR-mirna: a substudy of the TiMiSNAR Trial (NCT03962088).

Authors:  Igor Monsellato; Elisabetta Garibaldi; Elisa Cassinotti; Ludovica Baldari; Luigi Boni; Ugo Elmore; Roberto Delpini; Riccardo Rosati; Roberto Perinotti; Filippo Alongi; Elisa Bertocchi; Stefania Gori; Giacomo Ruffo; Graziano Pernazza; Fabio Pulighe; Carlo De Nisco; Emilio Morpurgo; Tania Contardo; Enzo Mammano; Federico Perna; Benedetta Menegatti; Andrea Coratti; Piero Buccianti; Riccardo Balestri; Cristina Ceccarelli; Davide Cavaliere; Leonardo Solaini; Giorgio Ercolani; Elena Traverso; Vittorio Fusco; Valter Torri; Sara Orecchia
Journal:  Trials       Date:  2020-07-25       Impact factor: 2.279

Review 7.  From tumor microenvironment communicants to biomarker discovery: Selectively packaged extracellular vesicular cargoes in pancreatic cancer.

Authors:  Song Han; Patrick Underwood; Steven J Hughes
Journal:  Cytokine Growth Factor Rev       Date:  2020-01-11       Impact factor: 7.638

8.  Exosomes in cancer: small vesicular transporters for cancer progression and metastasis, biomarkers in cancer therapeutics.

Authors:  Atefe Abak; Alireza Abhari; Sevda Rahimzadeh
Journal:  PeerJ       Date:  2018-05-29       Impact factor: 2.984

Review 9.  Effect of exosomal miRNA on cancer biology and clinical applications.

Authors:  Zhenqiang Sun; Ke Shi; Shuaixi Yang; Jinbo Liu; Quanbo Zhou; Guixian Wang; Junmin Song; Zhen Li; Zhiyong Zhang; Weitang Yuan
Journal:  Mol Cancer       Date:  2018-10-11       Impact factor: 27.401

Review 10.  MicroRNAs as Immunotherapy Targets for Treating Gastroenterological Cancers.

Authors:  Yixin Yang; Christopher Alderman; Ayoub Sehlaoui; Yuan Xiao; Wei Wang
Journal:  Can J Gastroenterol Hepatol       Date:  2018-06-26
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.